QSI Net Income Growth
7.46%TTM
Period ending:
QSI TTM Net Income YoY %%
56.16%-239.51%
2021-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
QSI net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 19 observations from Dec 31, 2021 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 7.4583% | |
| -3.0768% | |
| -0.3287% | |
| -29.9275% | |
| -19.1496% | |
| -9.6915% | |
| -5.2595% | |
| 15.9904% | |
| 21.6491% | |
| 24.0366% | |
| 27.5456% | |
| 16.836% | |
| 0.9253% | |
| -2.1058% | |
| -39.4288% | |
| -71.3761% | |
| -75.5192% | |
| -210.9013% | |
| -159.4406% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All QSI financial metrics · QSI stock overview · How to interpret financial metrics
